HLB Life Science to Issue Convertible Bonds
HLB생명과학
067630
Signal Score
Historical Avg Return (5d)
+0.72%
Data Coverage
100%n=2270
Risk-adjusted indicator based on 2270 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Total CB amount: 10,000,000,000 KRW
- • Early redemption rate (1st): 110.4486%
2 more figures — Starter & Pro plans
AI Analysis Summary
HLB Life Science CO.,LTD. has decided to issue convertible bonds totaling 10,000,000,000 KRW. The bonds include early redemption options, with rates ranging from 110.4486% (June 8, 2028) to 126.6209% (March 8, 2031). The company will provide collateral, including land and buildings, for the bonds. The issuance could lead to future share dilution, negatively impacting existing shareholders.
Risk Factors
Pro plan
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Price reaction & historical pattern data
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.